This stock is controlled by hedge funds, and I sincerely doubt it will ever make the Nasdaq. If it does I will take a look at it, but certainly not before.
I dumped it yesterday, will put my money elsewhere. A 5% drop in a mutual fund is too big when everything else in the market is going well.
Oops. Looks like you have over $20/share profit. That's terrific and you should sell some (50%) soon. Remember: Bulls make money, bears make money, pigs get slaughtered. Greed will destroy you in the market.
So you have made four bucks profit on your shares and you are not diversified? If I was in your shoes I would sell half of your shares and put the money in an no-load, aggressive equity mutual fund. That may sound dull to you but if you have only $100K in stocks you want to build capital so you can -then- make some speculative plays. And, you will sleep soundly. Remember, things can go wrong with these small biotech companies, even ACAD which is relatively safe. BTW, my portfolio is several times what you have, and I've been investing on my own for 35+ years.
Take a look at the SEC filings, especially those regarding ownership. It seems that Genesis had some hedge fund managers on its BoD, and that they bailed before Genesis became LION, I'm not sure why. Suffice it to say Genesis may have had some rather smarmy guys in high places. I'm done now but (as I said earlier) will keep an eye on LBIO.
My thought exactly. I have wondered if the numbers got screwed up somehow. None of the leading stocks in the portfolio tanked, so . . . ?
You make some very good points in your second paragraph especially, and I can relate to them because I invested in Celgene when thalidomide was a bad word and Revlimid was being regarded with great suspicion for that reason.
I do remain concerned about the one man show that is Singh, but maybe he's a wizard or a genius who can marshal forces to create a successful company. Suffice it to say I still have my doubts, and I do not see IMUC as a very successful enterprise despite the fact that Singh did fairly well with it during his tenure there. And, I wonder what prompted the morphing of Genesis into LION after his brief leadership with the former company.
You might want to look at Quogue Capital. The $23 million appears to have come from that outfit which consists (again) of one human being who invests in small biotechs. Now, that person could be a genius like Singh, or he could be a hedge fund guru who is cranking up the value of LBIO stock until he pulls the plug. That possibility makes me nervous. I have also been unable to find out much about Mr. Quogue other than the fact that he owns a huge estate in the Hamptons and appears to be very well-heeled.
Again, I have not dismissed the possibility of investing in LBIO, and may go long at some time in the future. In all probability that would not be before it is listed on Nasdaq, but I keep my options open.
I'm not a paid basher, but a guy who looked at this stock and considered going long with it. When I did DD I discovered that it is a company run by a handful of individuals, that its major funding comes from a "fund" that is a one-person affair, and that the science its approach is based upon harks four years back to one article by a guy with no known affiliation to LBIO. If those aren't red flags, I don't know what one is.
I do not have a position with LBIO and -- as I stated elsewhere -- I have never gone short on any stock. I will continue to watch LBIO, and if the situation changes appreciably may someday go long. I currently have long positions in CELG, SGMO, ACAD, CRMD, PATH, XON, ZIOP, so am no stranger to biotechs and have done well with them, particularly CELG. At this time, LBIO is simply too risky for me to buy it.
Now I do hope that I am wrong about LBIO and that you and the other longs here make tons of money with your investment, but I am very concerned that you will see the pps move up astronomically only to watch it crash and burn. Maybe you make money riding it up. Set your stops but watch that you aren't stopped out.
I am not going to post here anymore but I will be keeping an eye on LBIO.
Good luck with your investments.
The much touted research cited on this company's website is from a seven page article by Rosenberg & Dudley published in April, 2009, which means the actual data was collected well before that time. I can find no reference to Genesis Bioscience, LION, Singh, or IMUC in that article.
I'm willing to admit I was wrong here. Insofar as I can determine, Singh started on 02/18/08 and departed 12/03/13. PPS to start was $.53 and when leaving $3.20. So, maybe I was unfair to Singh. Volatility in PPS was noteworthy, however.
Compare R&D (this year and last year) with "Selling General and Administrative." Just where is that money going . . . surely not to research . . . hmmm . . . .
That $27 million came from -one- person, Wayne Rothbaum, who -is- "Quogue Capital." What that means is that LBIO is being financed by an individual who can easily manipulate the price per share, up or down as meets his needs. He lives in a castle on the Atlantic shore in the Hamptons and "invests" in other small, easily manipulated biotechs. At least check it out before you plunk your money down.
The prices cited are correct for 01/01/2008 through 12/31/2012, but of course there was variation between those dates, and some investors may have been able to capitalize on that, including you . . . but please don't tell me IMUC had stellar performance when Singh was there, for pps never got anywhere near five bucks.